Skip to content
healthcare.dev

MACI

NDC 69866-1030, autologous cultured chondrocytes, implant, from Vericel Corporation.

Product NDC
69866-1030
Status
Listed
Labeler
Vericel Corporation
Dosage form
IMPLANT
Route
INTRA-ARTICULAR
Product type
CELLULAR THERAPY
Marketing category
BLA
Application
BLA125603
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69866-1030 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AUTOLOGOUS CULTURED CHONDROCYTES15000000 1/1
  • PORK COLLAGEN15 cm2/1

Pharmacologic classes

Autologous Cultured Cell [EPC]; Cells, Cultured, Autologous [EXT]; Chondrocytes [CS]

Package NDCNDC-11Package
69866-1030-5698661030051 BAG in 1 BOX (69866-1030-5) / 1 BOTTLE, PLASTIC in 1 BAG (69866-1030-4) / 1 IMPLANT in 1 BOTTLE, PLASTIC (69866-1030-3)
69866-1030-8698661030082 BAG in 1 BOX (69866-1030-8) / 1 BOTTLE, PLASTIC in 1 BAG (69866-1030-7) / 1 IMPLANT in 1 BOTTLE, PLASTIC (69866-1030-6)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 69866-1030 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69866-1030 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69866-1030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.